Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Telomerase gene promoter (TERT) mutation in recurrent uveal melanoma after secondary enucleation revealed by targeted next-generation sequencing

Brittany Marie Perzia; Jacob S Heng; John Sinard; Renelle Lim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2350 – A0019.

ARVO Annual Meeting Abstract June 2021

The Natural History of Choroidal Melanoma: A Systematic Review and Meta-analysis

Elton K Zhou; Liangbo Linus Shen; Aneesha Ahluwalia; Sumun Khetpal; Mengyuan Sun; Ramsey Yusuf; Holly Grossetta Nardini; Renelle Pointdujour-Lim; Lucian V Del Priore

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2862.

ARVO Annual Meeting Abstract July 2019

Risk Factors for Poor Visual Outcomes in Patients That Develop Uveitis After Treatment with Checkpoint Inhibitors

Marez Megalla; Harriet Kluger; Sarah Weiss; Renelle Pointdujour-Lim; Ninani Kombo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3533.

ARVO Annual Meeting Abstract July 2018

Checkpoint inhibitor-induced ocular inflammation and adverse effects: an institutional case series

Jenna M Kim; Renelle P Lim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4309.

ARVO Annual Meeting Abstract June 2015

Photodynamic Therapy for Symptomatic Choroidal Nevi in 23 Cases

Wasim A Samara; Chloe TL Khoo; Renelle Pointdujour Lim; George Magrath; Arman Mashayekhi; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3441.

ARVO Annual Meeting Abstract June 2015

Rescue Intra-Arterial Chemotherapy Following Retinoblastoma Recurrence After Initial Intra-Arterial Chemotherapy

Renelle Pointdujour Lim; Emil A Say; Christopher Cao; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6058.

Advertisement